Glen Eagle Advisors’s Globus Medical GMED Stock Holding History

Glen Eagle Advisors’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$862	Hold	10	–	–	﹤0.01%	939
2025 Q4	$873	Hold	10	–	–	﹤0.01%	972
2025 Q3	$573	Hold	10	–	–	﹤0.01%	1043
2025 Q2	$590	Hold	10	–	–	﹤0.01%	972
2025 Q1	$732	Hold	10	–	–	﹤0.01%	960
2024 Q4	$827	Hold	10	–	–	﹤0.01%	986
2024 Q3	$715	Hold	10	–	–	﹤0.01%	1041
2024 Q2	$685	Hold	10	–	–	﹤0.01%	1045
2024 Q1	$536	Hold	10	–	–	﹤0.01%	1024
2023 Q4	$533	Hold	10	–	–	﹤0.01%	966
2023 Q3	$497	Hold	10	–	–	﹤0.01%	969
2023 Q2	$596	Hold	10	–	–	﹤0.01%	994
2023 Q1	$566	Hold	10	–	–	﹤0.01%	995
2022 Q4	$743	Hold	10	–	–	﹤0.01%	1044
2022 Q3	$596	Hold	10	–	–	﹤0.01%	1012
2022 Q2	$561	Hold	10	–	–	﹤0.01%	933
2022 Q1	$738	Hold	10	–	–	﹤0.01%	884
2021 Q4	$722	Hold	10	–	–	﹤0.01%	877
2021 Q3	$766	Hold	10	–	–	﹤0.01%	999
2021 Q2	$775	Hold	10	–	–	﹤0.01%	980
2021 Q1	$617	Hold	10	–	–	﹤0.01%	962
2020 Q4	$652	Hold	10	–	–	﹤0.01%	933
2020 Q3	$495	Hold	10	–	–	﹤0.01%	883
2020 Q2	$477	Hold	10	–	–	﹤0.01%	853
2020 Q1	$425	Hold	10	–	–	﹤0.01%	790
2019 Q4	$589	Hold	10	–	–	﹤0.01%	857
2019 Q3	$511	Hold	10	–	–	﹤0.01%	779
2019 Q2	$423	Hold	10	–	–	﹤0.01%	761
2019 Q1	$494	Buy	+10	New	+$452	﹤0.01%	721

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Glen Eagle Advisors's GMED Position: Q1 2026 in Review

Glen Eagle Advisors held its Globus Medical (GMED) position steady in Q1 2026 at 10 shares worth $862. The position accounts for ﹤0.01% of the portfolio, ranked #939.

Glen Eagle Advisors first reported a position in GMED in Q1 2019 and has held it in 29 quarters since. The position peaked at $873 in Q4 2025. 602 funds tracked by Wall St. Rank hold GMED as of Q1 2026.

Glen Eagle Advisors held 10 shares of Globus Medical worth $862 as of Q1 2026.
Glen Eagle Advisors left its Globus Medical share count unchanged in Q1 2026.
Globus Medical made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q1 2026, its #939 holding.
Glen Eagle Advisors first reported a position in Globus Medical in Q1 2019 and has held it in 29 quarters since.
Glen Eagle Advisors's Globus Medical position peaked at $873 in Q4 2025.
602 funds tracked by Wall St. Rank held Globus Medical as of Q1 2026.

Based on Glen Eagle Advisors's 13F filing for Q1 2026, filed 15 May 2026.